Stemtech Corp (STEK) Current Deferred Revenue (2022 - 2026)
Stemtech (STEK) posted Current Deferred Revenue of $335219.0 for Q1 2026, up 95.48% sequentially from $171485.0 in Q4 2025, and up 4845.69% YoY from $6778.0 in Q1 2025.
Stemtech Corp (STEK) Current Deferred Revenue (2022 - 2026) Analysis & Trends
Stemtech has reported Current Deferred Revenue for 5 years, with the latest figure at $335219.0 in Q1 2026.
- Quarterly Current Deferred Revenue rose 4845.69% year-over-year to $335219.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $335219.0 (up 4845.69% YoY) and the FY2025 annual result came in at $171485.0, up 11621.46% from the prior year.
- Current Deferred Revenue improved to $335219.0 in Q1 2026 per STEK's latest filing, from $171485.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $335219.0 in Q1 2026 and troughed at $1463.0 in Q4 2024.
- A 5-year average of $91044.1 and a median of $82392.0 in 2024 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue sank 97.39% in 2024, then soared 11621.46% in 2025.
- Over 5 years, Current Deferred Revenue stood at $39170.0 in 2022, then jumped by 43.07% to $56039.0 in 2023, then tumbled by 97.39% to $1463.0 in 2024, then jumped by 11621.46% to $171485.0 in 2025, then soared by 95.48% to $335219.0 in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $335219.0, $171485.0, and $88393.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 335,219.00 |
| Dec 31, 2025 | 171,485.00 |
| Sep 30, 2025 | 88,393.00 |
| Jun 30, 2025 | 98,249.00 |
| Mar 31, 2025 | 6,778.00 |
| Dec 31, 2024 | 1,463.00 |
| Jun 30, 2024 | 92,777.00 |
| Mar 31, 2024 | 82,392.00 |
| Dec 31, 2023 | 56,039.00 |
| Sep 30, 2023 | 82,835.00 |
| Jun 30, 2023 | 52,866.00 |
| Mar 31, 2023 | 75,907.00 |
| Dec 31, 2022 | 39,170.00 |